The effect of anti-tuberculosis treatment on levels of anti-phospholipid and anti-neutrophil cytoplasmatic antibodies in patients with active tuberculosis

Rheumatology International

Volumn 33, Issue 4, 2013, Pages 949-953

  Elkayam, Ori ^a   Bendayan, Daniele ^b   Segal, Refael ^b   Shapira, Yinon ^c,d   Gilburd, Boris ^c,d   Reuter, Sandra ^d   Agmon Levin, Nancy ^c,d   Shoenfeld, Yehuda ^c,d,e  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b Tel Aviv University Sackler Faculty of Medicine   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d AIRA eV AESKUKIPP Institute   (Germany)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

ANCA; Anti phospholipid; MPO; PR3; Tuberculosis

Indexed keywords

AUTOANTIBODY; BACTERICIDAL PERMEABILITY INCREASING PROTEIN ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LACTOFERRIN ANTIBODY; MYELOPEROXIDASE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTEINASE 3 ANTIBODY; PROTHROMBIN ANTIBODY; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CRYOPRESERVATION; DISEASE ACTIVITY; DRUG EFFECT; ENZYME IMMUNOASSAY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LUNG TUBERCULOSIS; MALE; MIDDLE AGED; MILIARY TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; TUBERCULOSIS; VERY ELDERLY; YOUNG ADULT; BLOOD; IMMUNOLOGY; QUESTIONNAIRE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTIPHOSPHOLIPID; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84886614213     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2487-0     Document Type: Article

References (25)

1. Malaviya AN, Kotwal PP (2003) Arthritis associated with tuberculosis. Best Pract Res Clin Rheumatol 17: 319-343
2. Watts HG, Lifeso RM (1996) Tuberculosis of bones and joints. J Bone Jt Surg 78: 288-298
3. Brown FS, Anderson RH, Burnett JW (1982) Cutaneous tuberculosis. Am Acad Dermatol 6: 101-106
4. Elkayam O, Gat A, Lidgi M, Segal R, Yaron M, Caspi D (2003) Atypical cutaneous findings in a patient with systemic lupus erythematosus. Lupus 12: 413-417
5. Elkayam O, Caspi D, Lidgi M, Segal R (2007) Auto-antibody profiles in patients with active pulmonary tuberculosis. Int J Tuberc Lung Dis 11: 306-310
6. Elkayam O, Segal R, Lidgi M, Caspi D (2006) Positive anticyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis 65:1110-1112. (Epub 2005 Dec 16)
7. Elkayam O, Segal R, Bendayan D, van Uitert R, Onnekink C, Pruijn GJ (2010) The anti-cyclic citrullinated peptide response in tuberculosis patients is not citrulline-dependent and sensitive to treatment. Arthritis Res Ther 12:R12. (Epub 2010 Jan 25)
8. Kakumanu P, Yamagata H, Sobel ES, Reeves WH, Chan EK, Satoh M (2008) Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide. Arthritis Rheum 58: 1576-1581
9. Adebajo AO, Charles P, Maini RN (1993) Hazleman BL Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population. Clin Exp Immunol 92: 73-76
10. McNally T, Purdy G, Mackie IJ, Machin SJ, Isenberg DA (1995) The use of an anti-beta 2-glycoprotein-I assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 91: 471-473
11. Hunt JE, McNeil HP, Morgan GJ, Crameri RM, Krilis SA (1992) A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1: 75-81
12. Ghosh K, Pradhan V, Ghosh K (2008) Background noise of infection for using ANCA as a diagnostic tool for vasculitis in tropical and developing countries. Parasitol Res 102:1093-1095. (Epub 2008 Feb 24)
13. Harada M, Fujisawa Y, Sakisaka S et al (2000) High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol 35: 272-277
14. Berlin T, Zandman-Goddard G, Blank M et al (2007) Autoantibodies in nonautoimmune individuals during infections. Ann N Y Acad Sci 1108: 584-593
15. Lehmann HW, Plentz A, von Landenberg P, Küster RM, Modrow S (2008) Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies. Clin Rheumatol 27:333-338. (Epub 2007 Sep 13)
16. Sène D, Piette JC, Cacoub (2008) Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun Rev 7:272-277. (Epub 2007 Oct 23)
17. Loizou S, Singh S, Wypkema E, Asherson RA (2003) Anticardiolipin, anti-beta(2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis 62: 1106-1111
18. Hojnik M, Gilburd B, Ziporen L et al (1994) Anticardiolipin antibodies in infections are heterogenous in their dependency on beta 2-glycoprotein I: analysis of anticardiolipin antibodies in leprosy. Lupus 3: 515-521
19. Arvieux J, Renaudineau Y, Mane I, Perraut R, Krilis SA, Youinou P (2002) Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome. Thromb Haemost 87: 599-605
20. Flores-Suárez LF, Cabiedes J, Villa AR, van der Woude FJ, Alcocer-Varela J (2003) Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis. Rheumatology (Oxford) 42: 223-229
21. Esquivel-Valerio JA, Flores-Su árez LF, Rodríguez-Amado J, Garza-Elizondo MA, Rendón A, Salinas-Carmona MC (2010) Antineutrophil cytoplasm autoantibodies in patients with tuberculosis are directed against bactericidal/permeability increasing protein and are detected after treatment initiation. Clin Exp Rheumatol 28(Suppl 57): 35-39
22. Sherkat R, Mostafavizadeh K, Zeydabadi L, Shoaei P, Rostami S (2011) Antineutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis. Iran J Immunol 8: 52-57
23. Pradhan VD, Badakere SS, Ghosh K, Pawar AR (2004) Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis overlaps with that of Wegener's granulomatosis. Indian J Med Sci 58: 283-288
24. Teixeira L, Mahr A, Jaureguy F et al. (2005) Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis. Rheumatology (Oxford) 44:247-250. (Epub 2004 Nov 16)
25. Siddiqui MA, Khan IA (2002) Isoniazid-induced lupus erythematosus presenting with cardiac tamponade. Am J Ther 9: 163-165